Social Media
Download
Download
Read Mode
Subscribe
Summarize

Overview

Eunize Lao has a corporate commercial practice with a focus on private equity and alternative fund investments, fund formation, mergers and acquisitions, corporate governance and commercial lending and financing. She advises fund sponsors and investors, including institutional investors, pension fund managers, corporate and government pension funds, university foundations and non-profit organizations on domestic and cross-border transactions. She also works with emerging and mid-sized companies, particularly in the biotechnology and technology sectors.

Eunize advises clients on investments in private equity and alternative funds, M&A transactions, corporate reorganizations and governance matters, as well as lending and financing arrangements. She works closely with clients to provide practical, business-focused advice across a range of complex corporate and commercial matters.

Eunize is a member of the Federation of Asian Canadian Lawyers British Columbia (FACL BC) and the National Asian Pacific American Bar Association (NAPABA). Before joining Bennett Jones as an associate, she articled at another national Canadian law firm in Vancouver.

Client Work

Medicus Pharma Ltd., (TSXV: MDCX; NASDAQ: MDCX), in its US IPO and NASDAQ-listing
Gibson Energy Inc. in its $403-million bought deal offering of subscription receipts.
Gibson Energy Inc., as Canadian counsel, in its US$1.1-billion acquisition of South Texas Gateway Terminal LLC.

Related Services

Education & Bar Admissions

Education

  • University of Waterloo, BA, 2018
  • University of British Columbia, JD, 2021

Bar Admissions

  • British Columbia, 2022